MMV Medicines for Malaria Venture
Geneva, Switzerland
Purpose
To evaluate a new, long-acting, oral endectocide to prevent malaria transmission in at-risk populations.
Division
Global Health
Date
September 2025
Region Served
AFRICA
Committed amount
$3,543,593
Grant topic
Malaria
Duration (months)
20
Grantee location
Geneva, Switzerland
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.